Complete tumor regressions were predominantly observed in animals treated with reovirus followed by mAb treatment (3/10 in the reo + anti-CD73 group, 4/9 in the reo + anti-PD-1 group, and 3/9 in the reo + combination antibody group). This evidence concerns the gene NT5E and neoplasm.